Sphingosine‐1‐Phosphate, Motor Severity, and Progression in Parkinson's Disease ( MARK‐PD )-Reference-Cited by-同舟云学术

Sphingosine‐1‐Phosphate, Motor Severity, and Progression in Parkinson's Disease ( MARK‐PD )

Published:2021-05-19 Issue:9 Volume:36 Page:2178-2182
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Schwedhelm Edzard¹²,Englisch Catrin³,Niemann Louisa³,Lezius Susanne⁴,Lucadou Mirjam¹²,Marmann Kristina¹,Böger Rainer¹²,Peine Sven⁵,Daum Günter²⁶,Gerloff Christian³,Choe Chi‐un³^ORCID

Affiliation:

1. Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg‐Eppendorf Hamburg Germany

2. German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/ Luebeck Hamburg Germany

3. Department of Neurology University Medical Center Hamburg‐Eppendorf Hamburg Germany

4. Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg‐Eppendorf Hamburg Germany

5. Institute of Transfusion Medicine, University Medical Center Hamburg‐Eppendorf Hamburg Germany

6. Department of Vascular Medicine University Heart and Vascular Center, Medical Center Hamburg‐Eppendorf Hamburg Germany

Funder

Else Kröner-Fresenius-Stiftung

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28652

Reference17 articles.

1. Parkinson's disease;Kalia LV;Lancet,2015

2. Inflammation in experimental models of alpha‐Synucleinopathies;Harms AS;Mov Disord,2020

3. Sphingosine‐1‐phosphate receptors modulators decrease signs of Neuroinflammation and prevent Parkinson's disease symptoms in the 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine mouse model;Pepin E;Front Pharmacol,2020

4. FTY720 improves behavior, increases brain derived neurotrophic factor levels and reduces alpha‐Synuclein pathology in parkinsonian GM2+/− mice;Vidal‐Martinez G;Neuroscience,2019

5. Sphingosine kinase 2 and sphingosine‐1‐phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ −treated MN9D cells in vitro;Sivasubramanian M;Neuroscience,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurolipid systems: A new target for the treatment of dementia;Basic & Clinical Pharmacology & Toxicology;2024-07-22

2. Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease;Neuroscience Letters;2024-01

3. TIC10/ONC201 Enhances Phosphate Uptake in the Human Neuroblastoma Cell Line SH-SY5Y;BPB Reports;2024

4. The role of sphingosine-1-phosphate in the development and progression of Parkinson’s disease;Frontiers in Cellular Neuroscience;2023-12-21

5. Metabolomic alterations in healthy adults traveling to low-pollution areas: A natural experiment with ozone exposure;Science of The Total Environment;2023-11